Getty Images

Chi Chi Gonzalez to undergo Tommy John surgery

1 Comment

Rangers’ right-hander Chi Chi Gonzalez is slated for Tommy John surgery, according to a report by Evan Grant of the Dallas Morning News. Gonzalez was placed on the 60-day disabled list back in early April with a partial UCL tear and was working towards a throwing program before getting sidelined with more elbow pain. He’s expected to miss the entirety of the 2018 season while recovering from the surgery.

This is the second straight season that has been derailed for Gonzalez due to injury. The 25-year-old starter pitched just 10 1/3 innings in 2016 after recovering from a torn UCL, and was optioned to Triple-A Round Rock to finish out the year after compiling an 8.71 ERA, 7.8 BB/9 and 6.1 SO/9 in three starts with the club. He showed more promise in Triple-A with a 4.70 ERA, 2.9 BB/9 and 5.9 SO/9 through 24 starts and 138 innings.

It’s a tough blow for the Rangers, who have seen Gonzalez healthy in just one major league season to date. General manager Jon Daniels told reporters that a recent MRI showed signs of weakening in the ligament, which disrupted the team’s plans to have the right-hander stick to a six- to eight-week recovery timetable after getting a platelet-rich plasma injection (via Stefan Stevenson of the Fort Worth Star-Telegram). The surgery is expected to take place next week and will put Gonzalez’s earliest return date sometime in September 2018.

Mets sign Matt Kemp to minor league deal

Matt Kemp
Getty Images
2 Comments

The Mets have had a lot of injuries in their outfield. How many? So many that they’re bringing in Matt Kemp, who they just signed on a minor league deal. Hey, why not? He’s functionally free.

Kemp was released by the Reds earlier this month after batting just .200/.210/.283 over 62 plate appearances. While he was a pretty useful player for the first half of the 2018 season for the Dodgers, the odds of him making major contributions to the Mets this year are probably about the same odds there were on Adrián González making an impact when the Mets signed him last year. But again: what’s the harm?